Department of Biomedical Sciences, Mercer University School of Medicine, Savannah, GA 31404, USA.
Department of Biomedical Sciences, Mercer University School of Medicine, Savannah, GA 31404, USA.
Virology. 2019 Mar;529:152-159. doi: 10.1016/j.virol.2019.01.003. Epub 2019 Jan 10.
Little is known about Epstein Barr Virus (EBV) proteins that participate in viral DNA cleavage and packaging. Genes encoding potential terminase subunit and portal protein homologs include BGRF1/BDRF1, BALF3, BFRF1A and BBRF1 respectively. EBV mutants with deletions in one or more of these genes were impaired for DNA packaging (Pavlova et al., 2013). In the current study, BBRF1 oligomers were purified from recombinant baculovirus infected insect cell extracts. Transmission electron microscopy revealed that purified EBV portals retained features typically found in other portals including a central channel with clip, stem and wing/crown domains. Although compounds have been identified that target DNA encapsidation in human cytomegalovirus, herpes simplex viruses and varicella-zoster virus, the identification of new EBV targets has lagged significantly. Characterization of the EBV portal will direct studies aimed at developing potential small molecular inhibitors of the EBV encapsidation process.
关于参与病毒 DNA 切割和包装的 Epstein Barr 病毒 (EBV) 蛋白,人们知之甚少。编码潜在末端酶亚基和门户蛋白同源物的基因分别包括 BGRF1/BDRF1、BALF3、BFRF1A 和 BBRF1。缺失这些基因之一或多个基因的 EBV 突变体在 DNA 包装方面存在缺陷(Pavlova 等人,2013 年)。在本研究中,从重组杆状病毒感染的昆虫细胞提取物中纯化了 BBRF1 寡聚体。透射电子显微镜显示,纯化的 EBV 门户保留了其他门户中通常发现的特征,包括带有夹、茎和翼/冠结构域的中央通道。尽管已经鉴定出针对人巨细胞病毒、单纯疱疹病毒和水痘带状疱疹病毒的 DNA 包裹的化合物,但 EBV 靶点的鉴定明显滞后。EBV 门户的特征描述将指导旨在开发 EBV 包裹过程潜在小分子抑制剂的研究。